{"acquisitions":[],"changes":[],"country":"DK","description":"SNIPR Biome is a Danish clinical-stage biotech developing CRISPR-based precision medicines that selectively kill harmful bacteria, led by SNIPR001 against drug-resistant E. coli. It targets patients at risk of life-threatening infections, like transplant patients. Its edge is microbiome-targeting CRISPR that spares commensal flora.","domain":"snipr.bio","employees":null,"founded":2017,"fundingTotalQuarantined":false,"githubOrg":"sniprbiome","githubStars":21,"industry":"unknown","industrySources":[],"investors":[],"lat":55.686724,"lng":12.570072,"location":"Copenhagen, Denmark","multiples":[],"name":"SNIPR Biome","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":37800000,"connectionsAmong":[],"currency":"EUR","date":"2025-08-15","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"snipr-bio-2025-08-15-series-b","source":{"fact":"round","publisher":"eu-startups","retrievedAt":"2026-05-07","status":"attributed","url":null},"status":"attributed","type":"series-b","url":null}],"slug":"snipr-bio","sources":[{"fact":"round","publisher":"eu-startups","retrievedAt":"2026-05-07","status":"attributed","url":null},{"fact":"existence","publisher":"snipr.bio","retrievedAt":"2026-05-07","status":"self-reported","url":"https://snipr.bio"},{"fact":"description","publisher":"snipr.bio","retrievedAt":"2026-05-07","status":"self-reported","url":"https://snipr.bio"}],"stage":"series-b+","stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":[],"totalRaisedUsd":108000000,"traction":[],"updatedAt":"2026-05-07","valuations":[]}